Sahakyan, Y., Erman, A. ., Bhojani, N. ., Chughtai, B. ., Zorn, K. C., Sander, B., & Elterman, D. S. (2022). Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia: A Canadian healthcare payer perspective. Canadian Urological Association Journal, 17(4), 103–10. https://doi.org/10.5489/cuaj.8045